Sat 9/22/2018 14:22 ET
DJIA26743.5086.520.32%TELCO170.491.500.88%GOLD1203.407.940.66%Shanghai2756.0127.010.98%
S&P 5002929.651.170.04%BANKS488.062.930.60%OIL70.720.400.57%BITCOIN6737.7024.260.36%
NASDAQ7986.9640.730.51%PHARM588.992.710.46%US/EU1.170.000.26%Futures2932.257.330.25%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Protalix BioTherapeutics - PLX   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add PLX
  
From: ZackMorris (Rep: 0)Date: 01/02/2018 08:27
Forum: Protalix BioTherapeutics - Msg #340Thread #673978230 (Rec: 0)
$PLX Protalix BioTherapeutics Reports Positive Interim Data from Phase II Clinical Trial of OPRX-106 in Patients with Ulcerative Colitis



Zack Attack!



NOTE: This message was originally posted on 2018-01-02 07:03:28 by the ZackMorris.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser ZackMorris: Reward | Watch | IgnorePLX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add PLX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.